CONTACT US  |  ACCOUNT LOGIN   THE VAP CHOLESTEROL TEST | ATHEROTECH DIAGNOSTIC TESTS | OUR HEALTHY HEART | THE LIPID LIBRARY | ABOUT ATHEROTECH   Management Company Overview Licenses &    Accreditations Press Kit Management Team Careers News Contact Us Executive Management Board of Directors Medical Advisory Board Michael V. Mullen President and Chief Executive Officer Robert Shufflebarger Chief Operating Officer Scott Rezek Chief Commercial Officer Michael E. Cobble, MD Chief Medical Officer Chuck Musial, CPA Chief Financial Officer Joseph Chimera, PhD Executive Vice President of Scientific Development Les Hric Chief Compliance Officer Kris Kulkarni, PhD Vice President of Research and Development Robert Flaherty Chairman of the Board James McClintic Director Grant Behrman Director Tom Perlmutter Director Michael V. Mullen President and Chief Executive Officer Atherotech Diagnostics Lab Michael E. Cobble, MD Chief Medical Officer Eliot A. Brinton, MD, FAHA, FNLA Michael H. Davidson, MD, FACC, FACP Prakash C. Deedwania, MD, FACC, FAHA, FACP, FCCP Peter H. Jones, MD, FACP, FNLA Steven R. Jones, M.D., F.A.C.C., A.B.C.L. Peter A. McCullough, M.D., M.P.H., F.A.C.C., F.A.C.P., F.C.C.P., F.A.H.A., F.N.K.F. John R. Nelson, MD, FACC Charles A. Reasner II, MD, FACE, FACP Peter Paul Tóth, MD, PhD, FAAFP, FICA, FAHA, FNLA, FCCP, FACC Robert A. Wild, MD, PhD, MPH "The VAP Test provides predictive factors for heart disease and allows physicians to manage therapy options for their diabetic patients at risk of heart attack and stroke." - Charles A. Reasner II, M.D., F.A.C.E., F.A.C.P., Professor of Medicine in the Department of Medicine, Division of Endocrinology, at the University of Texas Health Science Center (UTHSC) in San Antonio, Editor of the journal Practical Diabetology THE VAP CHOLESTEROL TEST  |  ATHEROTECH DIAGNOSTIC TESTS  |  OUR HEALTHY HEART  |  THE LIPID LIBRARY  |  ABOUT ATHEROTECH © Copyright 2013. Atherotech. All rights reserved.